WLDN vs. MAZE
WLDN (Willdan Group, Inc.) and MAZE (Maze Therapeutics, Inc) are both stocks. WLDN operates in Engineering & Construction (Industrials), while MAZE operates in Biotechnology (Healthcare). Over the past year, WLDN returned 72.52% vs 79.48% for MAZE. At a 0.12 correlation, their price movements are largely independent.
Performance
WLDN vs. MAZE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WLDN achieves a -7.10% return, which is significantly higher than MAZE's -41.95% return.
WLDN
- 1D
- -1.21%
- 1M
- 5.06%
- YTD
- -7.10%
- 6M
- -6.97%
- 1Y
- 72.52%
- 3Y*
- 71.89%
- 5Y*
- 19.75%
- 10Y*
- 24.56%
MAZE
- 1D
- -0.17%
- 1M
- -9.00%
- YTD
- -41.95%
- 6M
- -38.11%
- 1Y
- 79.48%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
WLDN vs. MAZE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
WLDN Willdan Group, Inc. | -7.10% | 184.78% |
MAZE Maze Therapeutics, Inc | -41.95% | 157.01% |
Correlation
The correlation between WLDN and MAZE is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Jan 31, 2025 | 0.12 |
Fundamentals
WLDN:
$1.48B
MAZE:
$1.30B
WLDN:
$3.71
MAZE:
-$2.63
WLDN:
4.78
MAZE:
3.79
WLDN:
$684.28M
MAZE:
$0.00
WLDN:
$261.18M
MAZE:
-$1.15M
WLDN:
$64.86M
MAZE:
-$126.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WLDN vs. MAZE — Risk / Return Rank
WLDN
MAZE
WLDN vs. MAZE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Willdan Group, Inc. (WLDN) and Maze Therapeutics, Inc (MAZE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| WLDN | MAZE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.22 | ||
| Sortino ratioReturn per unit of downside risk | -0.15 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.27 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.41 | 1.43 | -0.02 |
| Martin ratioReturn relative to average drawdown | 2.99 | 3.16 | -0.17 |
Loading charts...
Drawdowns
WLDN vs. MAZE - Drawdown Comparison
The maximum WLDN drawdown since its inception was -89.19%, which is greater than MAZE's maximum drawdown of -54.51%. Use the drawdown chart below to compare losses from any high point for WLDN and MAZE.
Loading charts...
Drawdown Indicators
| WLDN | MAZE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.19% | -54.51% | -34.68% |
Max Drawdown (1Y)Largest decline over 1 year | -50.41% | -54.51% | +4.10% |
Max Drawdown (3Y)Largest decline over 3 years | -50.41% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -72.59% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -78.71% | — | — |
Current DrawdownCurrent decline from peak | -28.63% | -53.60% | +24.97% |
Average DrawdownAverage peak-to-trough decline | -42.35% | -20.99% | -21.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.78% | 24.60% | -0.82% |
Volatility
WLDN vs. MAZE - Volatility Comparison
The current volatility for Willdan Group, Inc. (WLDN) is 8.81%, while Maze Therapeutics, Inc (MAZE) has a volatility of 11.72%. This indicates that WLDN experiences smaller price fluctuations and is considered to be less risky than MAZE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WLDN | MAZE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.81% | 11.72% | -2.91% |
Volatility (6M)Calculated over the trailing 6-month period | 50.77% | 56.26% | -5.49% |
Volatility (1Y)Calculated over the trailing 1-year period | 65.10% | 89.54% | -24.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 55.91% | 94.20% | -38.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 54.13% | 94.20% | -40.07% |
Dividends
WLDN vs. MAZE - Dividend Comparison
Neither WLDN nor MAZE has paid dividends to shareholders.
Financials
WLDN vs. MAZE - Financials Comparison
This section allows you to compare key financial metrics between Willdan Group, Inc. and Maze Therapeutics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
WLDN and MAZE have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MAZE has higher volatility (11.72%) compared to WLDN (8.81%). In terms of maximum drawdown, WLDN dropped -89.19% vs MAZE's -54.51%.
WLDN currently has the higher Sharpe Ratio (1.09 vs 0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for WLDN and MAZE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer